-
CDC: Acute Flaccid Myelitis Cases Appear to Have Peaked for 2018
drugs
December 04, 2018
he number of cases of acute flaccid myelitis (AFM) in the United States this year appears to have peaked and is expected to decline for the remainder of 2018.....
-
Asian Longhorned Tick Is Invading United States
drugs
November 30, 2018
Americans have unwelcome eight-legged visitors from the East, and they're here to stay.The Asian longhorned tick -- Haemaphysalis longicornis.....
-
BridgeBio Pharma Enters Genetic Disease Alliance
contractpharma
November 13, 2018
BridgeBio Pharma Enters Genetic Disease Alliance
-
Breakthrough research for diabetic kidney disease
biospectrum
November 12, 2018
A new mouse model accurately mimics diabetic kidney disease in humans, suggesting new approaches for treatment.
-
Half of all kidney cancer patients initially misdiagnosed
pharmafile
November 01, 2018
Half of all patients with kidney cancer are initially misdiagnosed, data from Kidney Cancer UK’s patient survey has revealed.
-
US team develops tool to identify disease-carrying mosquitoes
biospectrumasia
October 25, 2018
The tool comprises a smartphone camera, 3D-printed box and simple chemical test to assess if a dead mosquito is of the Aedes aegypti species.
-
Can aspirin treat Alzheimer's?
worldpharmanews
July 05, 2018
A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological researchers at Rush University Medical Center, who published the results of their stud
-
Ironwood Pharmaceuticals Initiates Pivotal Phase III Program for IW-3718 in Persistent Gastroesophageal Reflux Disease
americanpharmaceuticalreview
June 27, 2018
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company, today announced the initiation of two Phase III clinical trials evaluating the safety and efficacy of IW-3718 in patients with persistent gastroesophageal reflux disease (GERD).
-
Rare disease therapy Crysvita to be barred from NHS
pharmatimes
June 21, 2018
Children and young people with X-linked hypophosphataemia (XLH) are unlikely to get routine access to Kyowa Kirin’s Crysvita on the NHS.
-
Computer-aided facial analysis aids rare disease diagnosis
europeanpharmaceuticalreview
January 16, 2018
Using data on genetic material, cell surface texture and typical facial features, researchers have utilised artificial intelligence methods to simulate rare disease models…